Correlation between copy number variation genes (focal events) and selected clinical features
Uveal Melanoma (Primary solid tumor)
13 July 2018  |  None
Maintainer Information
Maintained by Broad Institute GDAC (Broad Institute of MIT & Harvard)
Overview
Introduction

This pipeline computes the correlation between significant copy number variation (cnv focal) genes and selected clinical features.

Summary

Testing the association between copy number variation 21 focal events and 7 clinical features across 80 patients, 10 significant findings detected with Q value < 0.25.

  • amp_6p24.3 cnv correlated to 'DAYS_TO_DEATH_OR_LAST_FUP'.

  • amp_8q11.22 cnv correlated to 'DAYS_TO_DEATH_OR_LAST_FUP'.

  • del_3p25.2 cnv correlated to 'DAYS_TO_DEATH_OR_LAST_FUP'.

  • del_3p25.1 cnv correlated to 'DAYS_TO_DEATH_OR_LAST_FUP'.

  • del_3p22.2 cnv correlated to 'DAYS_TO_DEATH_OR_LAST_FUP'.

  • del_3p14.2 cnv correlated to 'DAYS_TO_DEATH_OR_LAST_FUP'.

  • del_3q24 cnv correlated to 'DAYS_TO_DEATH_OR_LAST_FUP'.

  • del_3q29 cnv correlated to 'DAYS_TO_DEATH_OR_LAST_FUP'.

  • del_3q29 cnv correlated to 'DAYS_TO_DEATH_OR_LAST_FUP'.

  • del_8p11.22 cnv correlated to 'DAYS_TO_DEATH_OR_LAST_FUP'.

Results
Overview of the results

Table 1.  Get Full Table Overview of the association between significant copy number variation of 21 focal events and 7 clinical features. Shown in the table are P values (Q values). Thresholded by Q value < 0.25, 10 significant findings detected.

Clinical
Features
DAYS
TO
DEATH
OR
LAST
FUP
YEARS
TO
BIRTH
PATHOLOGIC
STAGE
PATHOLOGY
T
STAGE
PATHOLOGY
M
STAGE
GENDER RADIATION
THERAPY
nCNV (%) nWild-Type logrank test Wilcoxon-test Fisher's exact test Fisher's exact test Fisher's exact test Fisher's exact test Fisher's exact test
amp 6p24 3 47 (59%) 33 0.00431
(0.0634)
0.125
(0.46)
0.222
(0.573)
0.124
(0.46)
0.32
(0.627)
0.818
(1.00)
1
(1.00)
amp 8q11 22 48 (60%) 32 0.000136
(0.0025)
0.398
(0.72)
0.306
(0.614)
0.211
(0.569)
0.286
(0.595)
0.646
(0.931)
0.265
(0.591)
del 3p25 2 42 (52%) 38 4.36e-06
(0.000214)
0.216
(0.569)
0.0423
(0.368)
0.238
(0.573)
0.113
(0.456)
0.823
(1.00)
1
(1.00)
del 3p25 1 42 (52%) 38 4.36e-06
(0.000214)
0.216
(0.569)
0.0425
(0.368)
0.234
(0.573)
0.113
(0.456)
0.823
(1.00)
1
(1.00)
del 3p22 2 42 (52%) 38 4.36e-06
(0.000214)
0.216
(0.569)
0.0422
(0.368)
0.237
(0.573)
0.113
(0.456)
0.823
(1.00)
1
(1.00)
del 3p14 2 43 (54%) 37 9.35e-06
(0.000344)
0.172
(0.526)
0.0528
(0.431)
0.172
(0.526)
0.113
(0.456)
0.655
(0.934)
1
(1.00)
del 3q24 44 (55%) 36 1.89e-05
(0.000398)
0.287
(0.595)
0.037
(0.368)
0.109
(0.456)
0.117
(0.456)
0.824
(1.00)
1
(1.00)
del 3q29 44 (55%) 36 1.89e-05
(0.000398)
0.287
(0.595)
0.0371
(0.368)
0.107
(0.456)
0.117
(0.456)
0.824
(1.00)
1
(1.00)
del 3q29 44 (55%) 36 1.89e-05
(0.000398)
0.287
(0.595)
0.0381
(0.368)
0.109
(0.456)
0.117
(0.456)
0.824
(1.00)
1
(1.00)
del 8p11 22 19 (24%) 61 0.00399
(0.0634)
0.0801
(0.456)
0.0821
(0.456)
0.368
(0.694)
0.204
(0.569)
0.296
(0.604)
0.145
(0.497)
amp 8q24 22 61 (76%) 19 0.0233
(0.312)
0.582
(0.894)
0.86
(1.00)
0.495
(0.827)
0.562
(0.88)
0.427
(0.747)
1
(1.00)
del 1p36 12 25 (31%) 55 0.0849
(0.456)
0.0766
(0.456)
0.538
(0.86)
0.643
(0.931)
0.131
(0.47)
0.807
(1.00)
1
(1.00)
del 1p12 18 (22%) 62 0.271
(0.594)
0.212
(0.569)
0.707
(0.98)
1
(1.00)
0.265
(0.591)
0.172
(0.526)
0.503
(0.831)
del 2q37 2 4 (5%) 76 0.387
(0.72)
0.599
(0.899)
0.531
(0.857)
0.661
(0.934)
1
(1.00)
1
(1.00)
1
(1.00)
del 5q23 1 4 (5%) 76 0.191
(0.569)
0.401
(0.72)
0.675
(0.945)
0.814
(1.00)
1
(1.00)
0.309
(0.614)
1
(1.00)
del 6q25 3 26 (32%) 54 0.15
(0.5)
0.339
(0.653)
0.774
(1.00)
0.217
(0.569)
0.59
(0.894)
0.634
(0.931)
0.256
(0.591)
del 11q24 3 7 (9%) 73 0.393
(0.72)
0.074
(0.456)
0.964
(1.00)
0.866
(1.00)
1
(1.00)
0.456
(0.789)
1
(1.00)
del 16q22 1 18 (22%) 62 0.102
(0.456)
0.489
(0.827)
0.231
(0.573)
0.136
(0.478)
0.265
(0.591)
0.584
(0.894)
0.105
(0.456)
del 16q23 3 19 (24%) 61 0.104
(0.456)
0.509
(0.831)
0.342
(0.653)
0.161
(0.525)
0.265
(0.591)
0.79
(1.00)
0.118
(0.456)
del 17q12 3 (4%) 77 0.0675
(0.456)
0.617
(0.916)
0.414
(0.734)
0.557
(0.88)
1
(1.00)
1
(1.00)
1
(1.00)
del 18q22 2 4 (5%) 76 0.491
(0.827)
0.955
(1.00)
0.859
(1.00)
0.816
(1.00)
1
(1.00)
1
(1.00)
1
(1.00)
'amp_6p24.3' versus 'DAYS_TO_DEATH_OR_LAST_FUP'

P value = 0.00431 (logrank test), Q value = 0.063

Table S1.  Gene #1: 'amp_6p24.3' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

nPatients nDeath Duration Range (Median), Month
ALL 79 22 0.1 - 85.5 (26.1)
AMP PEAK 1(6P24.3) MUTATED 47 8 0.1 - 85.5 (27.0)
AMP PEAK 1(6P24.3) WILD-TYPE 32 14 0.2 - 61.2 (20.4)

Figure S1.  Get High-res Image Gene #1: 'amp_6p24.3' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

'amp_8q11.22' versus 'DAYS_TO_DEATH_OR_LAST_FUP'

P value = 0.000136 (logrank test), Q value = 0.0025

Table S2.  Gene #2: 'amp_8q11.22' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

nPatients nDeath Duration Range (Median), Month
ALL 79 22 0.1 - 85.5 (26.1)
AMP PEAK 2(8Q11.22) MUTATED 47 20 0.1 - 82.2 (23.3)
AMP PEAK 2(8Q11.22) WILD-TYPE 32 2 0.2 - 85.5 (31.3)

Figure S2.  Get High-res Image Gene #2: 'amp_8q11.22' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

'del_3p25.2' versus 'DAYS_TO_DEATH_OR_LAST_FUP'

P value = 4.36e-06 (logrank test), Q value = 0.00021

Table S3.  Gene #7: 'del_3p25.2' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

nPatients nDeath Duration Range (Median), Month
ALL 79 22 0.1 - 85.5 (26.1)
DEL PEAK 4(3P25.2) MUTATED 41 20 0.1 - 61.2 (21.0)
DEL PEAK 4(3P25.2) WILD-TYPE 38 2 0.2 - 85.5 (27.5)

Figure S3.  Get High-res Image Gene #7: 'del_3p25.2' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

'del_3p25.1' versus 'DAYS_TO_DEATH_OR_LAST_FUP'

P value = 4.36e-06 (logrank test), Q value = 0.00021

Table S4.  Gene #8: 'del_3p25.1' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

nPatients nDeath Duration Range (Median), Month
ALL 79 22 0.1 - 85.5 (26.1)
DEL PEAK 5(3P25.1) MUTATED 41 20 0.1 - 61.2 (21.0)
DEL PEAK 5(3P25.1) WILD-TYPE 38 2 0.2 - 85.5 (27.5)

Figure S4.  Get High-res Image Gene #8: 'del_3p25.1' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

'del_3p22.2' versus 'DAYS_TO_DEATH_OR_LAST_FUP'

P value = 4.36e-06 (logrank test), Q value = 0.00021

Table S5.  Gene #9: 'del_3p22.2' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

nPatients nDeath Duration Range (Median), Month
ALL 79 22 0.1 - 85.5 (26.1)
DEL PEAK 6(3P22.2) MUTATED 41 20 0.1 - 61.2 (21.0)
DEL PEAK 6(3P22.2) WILD-TYPE 38 2 0.2 - 85.5 (27.5)

Figure S5.  Get High-res Image Gene #9: 'del_3p22.2' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

'del_3p14.2' versus 'DAYS_TO_DEATH_OR_LAST_FUP'

P value = 9.35e-06 (logrank test), Q value = 0.00034

Table S6.  Gene #10: 'del_3p14.2' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

nPatients nDeath Duration Range (Median), Month
ALL 79 22 0.1 - 85.5 (26.1)
DEL PEAK 7(3P14.2) MUTATED 42 20 0.1 - 61.2 (22.1)
DEL PEAK 7(3P14.2) WILD-TYPE 37 2 0.2 - 85.5 (27.5)

Figure S6.  Get High-res Image Gene #10: 'del_3p14.2' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

'del_3q24' versus 'DAYS_TO_DEATH_OR_LAST_FUP'

P value = 1.89e-05 (logrank test), Q value = 4e-04

Table S7.  Gene #11: 'del_3q24' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

nPatients nDeath Duration Range (Median), Month
ALL 79 22 0.1 - 85.5 (26.1)
DEL PEAK 8(3Q24) MUTATED 43 20 0.1 - 61.2 (23.3)
DEL PEAK 8(3Q24) WILD-TYPE 36 2 0.2 - 85.5 (27.3)

Figure S7.  Get High-res Image Gene #11: 'del_3q24' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

'del_3q29' versus 'DAYS_TO_DEATH_OR_LAST_FUP'

P value = 1.89e-05 (logrank test), Q value = 4e-04

Table S8.  Gene #12: 'del_3q29' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

nPatients nDeath Duration Range (Median), Month
ALL 79 22 0.1 - 85.5 (26.1)
DEL PEAK 9(3Q29) MUTATED 43 20 0.1 - 61.2 (23.3)
DEL PEAK 9(3Q29) WILD-TYPE 36 2 0.2 - 85.5 (27.3)

Figure S8.  Get High-res Image Gene #12: 'del_3q29' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

'del_3q29' versus 'DAYS_TO_DEATH_OR_LAST_FUP'

P value = 1.89e-05 (logrank test), Q value = 4e-04

Table S9.  Gene #13: 'del_3q29' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

nPatients nDeath Duration Range (Median), Month
ALL 79 22 0.1 - 85.5 (26.1)
DEL PEAK 10(3Q29) MUTATED 43 20 0.1 - 61.2 (23.3)
DEL PEAK 10(3Q29) WILD-TYPE 36 2 0.2 - 85.5 (27.3)

Figure S9.  Get High-res Image Gene #13: 'del_3q29' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

'del_8p11.22' versus 'DAYS_TO_DEATH_OR_LAST_FUP'

P value = 0.00399 (logrank test), Q value = 0.063

Table S10.  Gene #16: 'del_8p11.22' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

nPatients nDeath Duration Range (Median), Month
ALL 79 22 0.1 - 85.5 (26.1)
DEL PEAK 13(8P11.22) MUTATED 19 10 0.1 - 61.2 (23.3)
DEL PEAK 13(8P11.22) WILD-TYPE 60 12 0.2 - 85.5 (26.4)

Figure S10.  Get High-res Image Gene #16: 'del_8p11.22' versus Clinical Feature #1: 'DAYS_TO_DEATH_OR_LAST_FUP'

Methods & Data
Input
  • Copy number data file = all_lesions.txt from GISTIC pipeline

  • Processed Copy number data file = /cromwell_root/fc-f5144117-2d5a-42c2-8998-5b38e52db5d9/852a61f5-e734-402b-a7d5-7b508460e2ea/correlate_genomic_events_all/1ec834d1-534b-4843-b535-2942ce5ba9b8/call-preprocess_genomic_event/transformed.cor.cli.txt

  • Clinical data file = /cromwell_root/fc-2289d790-de74-4808-9b0a-cefafc34d859/0d7c7dcf-18e0-4b2d-afc0-a0b2ee1e45ff/preprocess_clinical_workflow/70152ac6-f707-4277-8d60-8770b1b366c6/call-preprocess_clinical/TCGA-UVM-TP.clin.merged.picked.txt

  • Number of patients = 80

  • Number of significantly focal cnvs = 21

  • Number of selected clinical features = 7

  • Exclude genes that fewer than K tumors have mutations, K = 3

Survival analysis

For survival clinical features, the Kaplan-Meier survival curves of tumors with and without gene mutations were plotted and the statistical significance P values were estimated by logrank test (Bland and Altman 2004) using the 'survdiff' function in R

Fisher's exact test

For binary or multi-class clinical features (nominal or ordinal), two-tailed Fisher's exact tests (Fisher 1922) were used to estimate the P values using the 'fisher.test' function in R

Q value calculation

For multiple hypothesis correction, Q value is the False Discovery Rate (FDR) analogue of the P value (Benjamini and Hochberg 1995), defined as the minimum FDR at which the test may be called significant. We used the 'Benjamini and Hochberg' method of 'p.adjust' function in R to convert P values into Q values.

References
[1] Bland and Altman, Statistics notes: The logrank test, BMJ 328(7447):1073 (2004)
[2] Fisher, R.A., On the interpretation of chi-square from contingency tables, and the calculation of P, Journal of the Royal Statistical Society 85(1):87-94 (1922)
[3] Benjamini and Hochberg, Controlling the false discovery rate: a practical and powerful approach to multiple testing, Journal of the Royal Statistical Society Series B 59:289-300 (1995)